trafermin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
We investigated the efficacy, safety, and clinical significance of trafermin, a recombinant human fibroblast growth factor (rhFGF…
Introduction: Basic fibroblast growth factor (bFGF) has been shown to reduce volume in acute ischemic stroke models, and to…
Objective: To present the clinical results of closing chronic tympanic membrane (TM) perforations using basic fibroblast growth…
BACKGROUND
Aplasia cutis congenita (ACC) is a condition in which localized or widespread areas of skin are absent at birth…
We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that…
Trafermin, a form of basic fibroblast growth factor, has been used in Japan since 2001. This study investigates whether it can…
Aim: Clinical researches using allogeneic CDS, developed in the R & D Center for Artificial Skin of Kitasato University, have…
Objective To present a new method for closing tympanic membrane perforations using basic fibroblast growth factor (bFGF) combined…
Background: Trafermin (basic fibroblast growth factor) has been shown to reduce infarct volume in acute ischemic stroke models…
The fate of trafermin (recombinant human basic fibroblast growth factor) was examined after intravenous administration of its…